Welcome! The Bloomington Life Sciences Partnership is a collaborative effort dedicated to continued life sciences business growth in greater Bloomington, Indiana - a nationally recognized leading metro area in medical devices, contract pharma, biotechnology, basic research and life sciences workforce development.

The Mill’s 2nd Annual INX Pitch Event Sends Five Qualifiers to Indy for INX

August 6, 2018 FOR IMMEDIATE RELEASE For more information, please contact: Pat East pat.east@cofoundventures.com 317.965.2155 Bloomington, Ind – Dimension Mill’s 2nd Annual INX Pre-Qualification Pitch Event was held on Wednesday, July 25th, 2018. Twelve pitches were presented at the event. Five were chosen to qualify for a trip to Indianapolis. Participants were given seven minutes to pitch their business, and seven minutes for a brief question and answer session led by the judges. The judges for this event were Mark Gramelspacher, EIR at Elevate Ventures;, the state’s venture capital fund Oscar Morales, Founder & Managing Director at VisionTech, the state’s largest angel group; and Teri Willey, Executive Director & Fund Manager at the IU Philanthropic Venture Fund, their new $15mm startup fund. The judges, prominent and respected investors in Indiana’s startup community, were impressed by the wide array of innovative companies that participated, and chose five winners from the twelve participants at the event. The five winners of the event, held at the Hoosier Energy complex in Bloomington, are a diverse set of companies that showcase the immense creativity of the startup community that The Mill plans to grow with its 19,000 square-foot facility, which seeks to be a hub of startup innovation and investment for Bloomington. The winners of the pre-qualification event were diverse in their solutions and showcased the immense amount of talent and innovation that exists within the Bloomington and area communities: Underdog Apparel, a company looking to create unique high-quality apparel for underserved collegiate markets; ShipperTech, which provides a secure solution to buyers and sellers in online marketplaces like Craigslist; The Bee Corp, which provides a unique data-driven solution for growers and beekeepers; Wave Therapeutics, which provides a solution to reduce and eliminate bedsores and discomfort for patients in nursing homes and other medical facilities; and Heliponix, which has developed the GrowPodTM , a device that can grow fresh, organic produce in the convenience of the customer’s home. “This year’s event could not have gone better! Good attendance, 12 solid pitches, smooth logistics, 5 winners instead of 2 last year, the Hoosier Energy venue was world-class and impressive, and the judges were professional investors and their questions, critiques, and coaching were exactly what our startups needed,” said Pat East, Executive Director of The Mill. The Mill is a 19,000 square-foot coworking, community collaboration, and high-potential startup business incubation space scheduled for completion on October 31st, 2018.   Please follow and like...

Read More

BioCrossroads accepting entries for 2018 new venture competition

Since 2012, BioCrossroads’ New Venture Competition has uncovered a steady stream of the most promising life sciences startups by offering awards, recognition and venture capital. To date, the competition has awarded more than $350,000 to 23 startup companies, which have successfully gone on to secure an additional $35 million in follow-on funding. “Through the competition, we have identified the next generation of life sciences start-ups – both from research done in academic settings as well as from entrepreneurs working independently and from all corners of Indiana.” said David Johnson, president and CEO, BioCrossroads. “It’s been gratifying to see some of our winners from a few years ago make progress.  SpeechVive and Diagnotes have products in the market; 2013 winner Spensa Technologies was acquired; and Scioto BioSciences, who won in 2016, just raised nearly $ 2 million in venture capital from investors including BioCrossroads.” In addition to a cash prize of $25,000 and exposure to hundreds of influencers at the Summit, the winners of the New Venture Competition will have access to the Indiana Seed Fund (ISF) staff and the fund’s network of resources to provide business planning and early-stage strategic support. They will also have the opportunity to make a presentation to the ISF investment committee for added exposure. Second and third place companies will be awarded cash prizes of $15,000 and $10,000 respectively. The Competition is open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus to Indiana. Startups will enter a highly competitive process with first round applications due Aug. 13, 2018. Five finalists will compete for cash prizes Oct. 9 during the 2018 Indiana Life Sciences Summit and be announced at the reception that evening at the Marriott Downtown Indianapolis. Taft Stettinius & Hollister LLP is the presenting sponsor. VisionTech Partners, Metazoa Brewing Company, Halo Capital Group and 16 Tech are also supporting the Competition through judging and sponsorships. For additional information and to apply, please visit www.biocrossroads.com/newventure About BioCrossroads BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow the life sciences, a public-private collaboration that supports the region’s research and corporate strengths while encouraging new business development.   BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises, expands collaboration and partnerships among Indiana’s life science institutions, expands science education and markets Indiana’s life sciences industry.  The initiative has formed several new nonprofit organizations, including Indiana Health Information Exchange, BioCrossroadsLINX, OrthoWorx, Datalys Center and the Indiana Biosciences Research Institute. Please follow and like...

Read More
Sintact Medical Systems
Nov02

Sintact Medical Systems

Sintact Medical Systems Sintact Medical Systems, Inc. develops non-resorbable films that separate adjacent organs from attaching to each other after surgery. The Sintact film acts as a polymeric tissue substitute that separates organ and tissue surfaces to significantly reduce the likelihood of tissue attachment and associated post-operative complications. Company Information Address 113 E. 6th Street Bloomington, IN 47408 Website http://www.sintactmed.com   codepeople-post-map require JavaScript Please follow and like...

Read More